Umbilical cord blood transplantation has transformed the treatment options for patients with blood cancers and other life-threatening hematologic disorders, particularly when matched donors are ...

A Japanese study of more than 7,400 patients has identified a genetic mismatch that sharply increases the risk of severe acute graft-versus-host disease (GVHD) following umbilical cord blood ...

AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032, registering a CAGR of 7.47% during 2024--2032. Growth is underpinned by ...

Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information.

Umbilical cord blood transplantation has transformed the treatment options for patients with blood cancers and other life-threatening hematological ...

Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...

Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

Plants are constantly exposed to a wide array of biotic and abiotic stresses in their natural environments, posing ...

The PW Institute of Innovation (PW IOI), PhysicsWallah's higher education vertical, concluded RIFT '26, a 24-hour hackathon ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...

Fragments of DNA from long-extinct human relatives still circulate in modern genomes, and in some cases they do more than linger. They actively shape how people survive in extreme environments. The ...